Yossi Maimon
2013 - Protalix BioTherapeutics
In 2013, Yossi Maimon earned a total compensation of $974.8K as Vice President, Chief Financial Officer at Protalix BioTherapeutics, a 30% decrease compared to previous year.
Compensation breakdown
| Bonus | $110,000 |
|---|---|
| Option Awards | $126,208 |
| Salary | $292,096 |
| Stock Awards | $378,745 |
| Other | $67,739 |
| Total | $974,788 |
Maimon received $378.7K in stock awards, accounting for 39% of the total pay in 2013.
Maimon also received $110K in bonus, $126.2K in option awards, $292.1K in salary and $67.7K in other compensation.
Rankings
In 2013, Yossi Maimon's compensation ranked 6,729th out of 12,286 executives tracked by ExecPay. In other words, Maimon earned more than 45.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,729 out of 12,286 | 45th |
Division Manufacturing | 2,371 out of 4,614 | 49th |
Major group Chemicals And Allied Products | 715 out of 1,466 | 51st |
Industry group Drugs | 524 out of 1,160 | 55th |
Industry Biological Products, Except Diagnostic Substances | 86 out of 200 | 57th |
Source: SEC filing on July 1, 2016.
Maimon's colleagues
We found four more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2013.
2013
David Aviezer
Protalix BioTherapeutics
Chief Executive Officer
2013
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2013
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2013
Tzvi Palash
Protalix BioTherapeutics